Skip to main content

Advertisement

SpringerLink
Log in

Role of MMP-3 and MMP-9 and Their Haplotypes in Risk of Bladder Cancer in North Indian Cohort

  • Translational Research and Biomarkers
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

Abstract

Purpose

Matrix metalloproteinases (MMPs) play critical roles in cancer development and progression. Nonsynonymous single nucleotide polymorphisms (SNPs) in functional domain of MMP-3 and MMP-9 contribute appreciably to cancer predisposition and aggression. To test this proposition we examined whether six SNPs of the MMP-3 and MMP-9 genes are associated with risk of bladder cancer (BC) in a North Indian population.

Methods

Six SNPs of MMP-3 and MMP-9 were analyzed by polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) in a case–control study including 200 BC patients and 200 age/gender/ethnicity-matched controls.

Results

Increased risk for BC susceptibility was observed in MMP-3 (1171) 5A/5A [P = 0.022; odds ratio (OR), 3.46; 95% confidence interval (CI), 1.20–9.98], MMP-9 (Q279R) QQ (P = 0.048; OR, 1.92; 95%CI, 1.01–3.66), MMP-9 (P574R) PR (P < 0.001; OR, 2.62; 95%CI, 1.71–4.03) and PR + RR (P < 0.001; OR, 2.59; 95%CI, 1.72–3.91) genotypes, and in R allele (P < 0.001; OR, 2.05; 95%CI, 1.47–2.85). Furthermore, significant association between MMP-9 Q279R, P574R polymorphism and smoking was observed in BC risk. Haplotype analysis too revealed significant association with 5A-A-G of MMP-3 haplotype (P = 0.022; OR, 1.99; 95%CI, 1.11–3.60) and with R-R (P = 0.001; OR, 2.00; 95%CI, 1.35–2.97) and Q-R (P < 0.001; OR, 2.97; 95%CI, 1.65–5.37) of MMP-9 haplotype. Genotype 5A/6A of MMP-3-1171 showed borderline risk and high recurrence-free survival in Bacillus Calmette–Guérin (BCG)-treated non-muscle-invasive BC (NMIBC) patients (log-rank P = 0.025).

Conclusion

Our data suggested that MMP-3-1171 5A/5A and MMP-9 (Q279R) QQ, MMP-9 (P574R) PR, PR + RR, and R allele are associated with high risk of BC.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Curran S, Murray GI. Matrix metalloproteinases in tumour invasion and metastasis. J Pathol. 1999;189:300–8.

    Article  CAS  PubMed  Google Scholar 

  2. Stamenkovic I. Matrix metalloproteinases in tumor invasion and metastasis. Semin Cancer Biol. 2000;10:415–33.

    Article  CAS  PubMed  Google Scholar 

  3. Chambers AF, Matrisian LM. Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst. 1997;89:1260–70.

    Article  CAS  PubMed  Google Scholar 

  4. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Natl Rev Cancer 2002;2:161–74.

    Article  CAS  Google Scholar 

  5. Wilson CL, Matrisian LM. Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol. 1996;28:123–36.

    Article  CAS  PubMed  Google Scholar 

  6. Gerhards S, Jung K, Koenig F, Daniltchenko D, Hauptmann S, Schnorr D, et al. Excretion of matrix metalloproteinases 2 and 9 in urine is associated with a high stage and grade of bladder carcinoma. Urology. 2001;57:675–9.

    Article  CAS  PubMed  Google Scholar 

  7. Gohji K, Fujimoto N, Komiyama T, Fujii A, Ohkawa J, Kamidono S, et al. Elevation of serum levels of matrix metalloproteinase-2 and -3 as new predictors of recurrence in patients with urothelial carcinoma. Cancer. 1996;78:2379–87.

    Article  CAS  PubMed  Google Scholar 

  8. Zinzindohoué F, Lecomte T, Ferraz JM, et al. Prognostic significance of MMP-1 and MMP-3 functional promoter polymorphisms in colorectal cancer. Clin Cancer Res. 2005;11:594–9.

    PubMed  Google Scholar 

  9. Grieu F, Li WQ, Iacopetta B. Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype. Breast Cancer Res Treat. 2004;88:197–204.

    Article  CAS  PubMed  Google Scholar 

  10. Colombel M, Soloway M, Akaza H. Epidemiology, staging, grading and risk stratification of bladder cancer. Eur Urol Suppl. 2008;7:618–26.

    Article  Google Scholar 

  11. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res. 1988;16: 1215.

    Article  CAS  PubMed  Google Scholar 

  12. Shibata N, Ohnuma T, Higashi S, et al. Genetic association between matrix metalloproteinase MMP-9 and MMP-3 polymorphisms and Japanese sporadic Alzheimer’s disease. Neurobiol Aging. 2005;26:1011–4.

    Article  CAS  PubMed  Google Scholar 

  13. Wu J, Zhang L, Luo H, Zhu Z, Zhang C, Hou Y. Association of matrix metalloproteinases-9 gene polymorphisms with genetic susceptibility to esophageal squamous cell carcinoma. DNA Cell Biol. 2008;27:553–7.

    Article  CAS  PubMed  Google Scholar 

  14. Zhang J, Jin X, Fang S, et al. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma. Carcinogenesis. 2005;26:1748–53.

    Article  CAS  PubMed  Google Scholar 

  15. Ye S, Eriksson P, Hamsten A, Kurkinen M, Humphries SE, Henney AM. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J Biol Chem. 1996;271:13055–60.

    Article  CAS  PubMed  Google Scholar 

  16. Ye S, Watts GF, Mandalia S, Humphries SE, Henney AM. Preliminary report: genetic variation in the human stromelysin promoter is associated with progression of coronary atherosclerosis. Br Heart J. 1995;73:209–15.

    Article  CAS  PubMed  Google Scholar 

  17. Hinoda Y, Okayama N, Takano N, et al. Association of functional polymorphisms of matrix metalloproteinase (MMP)-1 and MMP-3 genes with colorectal cancer. Int J Cancer. 2002;102:526–9.

    Article  CAS  PubMed  Google Scholar 

  18. Ghilardi G, Biondi ML, Caputo M, Leviti S, DeMonti M, Guagnellini E, et al. A single nucleotide polymorphism in the matrix metalloproteinase-3 promoter enhances breast cancer susceptibility. Clin Cancer Res. 2002;8:3820–3.

    CAS  PubMed  Google Scholar 

  19. St-Pierre Y, Van Themsche C, Estève PO. Emerging features in the regulation of MMP-9 gene expression for the development of novel molecular targets and therapeutic strategies. Curr Drug Targets Inflamm Allergy. 2003;2:206–15.

    Article  CAS  PubMed  Google Scholar 

  20. Matsumura S, Oue N, Nakayama H, et al. A single nucleotide polymorphism in the MMP-9 promoter affects tumor progression and invasive phenotype of gastric cancer. J Cancer Res Clin Oncol. 2005;131:19–25.

    Article  CAS  PubMed  Google Scholar 

  21. Hu Z, Huo X, Lu D, et al. Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer. Clin Cancer Res. 2005;11:5433–9.

    Article  CAS  PubMed  Google Scholar 

  22. Cotignola J, Reva B, Mitra N, et al. Metalloproteinase-9 (MMP-9) polymorphisms in patients with cutaneous malignant melanoma. BMC Med Genet. 2007;8:10.

    Article  PubMed  Google Scholar 

  23. Awakura Y, Ito N, Nakamura E, et al. Matrix metalloproteinase-9 polymorphisms and renal cell carcinoma in a Japanese population. Cancer Lett. 2006;241:59–63.

    Article  CAS  PubMed  Google Scholar 

  24. Tang Y, Zhu J, Chen L, Chen L, Zhang S, Lin J. Associations of matrix metalloproteinase-9 protein polymorphisms with lymph node metastasis but not invasion of gastric cancer. Clin Cancer Res. 2008;14:2870–7.

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

The study was funded by Department of Science and Technology, New Delhi, Govt. of India.

Author information

Authors and Affiliations

  1. Department of Urology and Renal Transplantation, Sanjay Gandhi Post Graduate Institute of Medical Sciences, Lucknow, Uttar Pradesh, India

    Priyanka Srivastava MSc, Anil Mandhani MCh, Rakesh Kapoor MCh & Rama D. Mittal PhD

Authors
  1. Priyanka Srivastava MSc
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anil Mandhani MCh
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rakesh Kapoor MCh
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rama D. Mittal PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rama D. Mittal PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Srivastava, P., Mandhani, A., Kapoor, R. et al. Role of MMP-3 and MMP-9 and Their Haplotypes in Risk of Bladder Cancer in North Indian Cohort. Ann Surg Oncol 17, 3068–3075 (2010). https://doi.org/10.1245/s10434-010-1153-6

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-010-1153-6

Keywords

Search

Navigation